Using Addiction Comprehensive Health Enhancement Support System (ACHESS) in an Alcoholic Liver Disease Population

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03388320

Enrollment

Registered

2018-01-02

Start date

2018-04-24

Completion date

2021-12-01

Last updated

2019-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases, Alcoholic

Brief summary

This is a pilot study examining whether an evidence-based recovery support smartphone application, the Addiction Comprehensive Health Enhancement Support System (A-CHESS), can decrease alcohol recidivism in a previously unstudied group of patients with alcoholic liver disease (ALD).

Detailed description

A-CHESS is a smartphone application developed by the University of Wisconsin-Madison based on self-determination theory, with a previous randomized clinical trial showing that use of the app resulted in significantly fewer risky drinking days in patients leaving treatment for alcohol-use disorders. The application is downloaded to the participant's smartphone, and provides ongoing access to peer support and educational materials, monitoring of the risk of relapse, and delivery of reminders and encouragements to the patient. The application also has a survey platform to assess and reassess the participants' most recent alcohol consumption, quality of life, and experience using the application. We anticipate that use of the A-CHESS app will result in decreased drinking and improved abstinence, identifying a potential intervention to offer patients with ALD to improve their mortality, liver disease, and likelihood of liver transplant candidacy status.

Interventions

DEVICEA-CHESS

Use of smartphone application: Addiction Comprehensive Health Enhancement Support System (A-CHESS)

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Alcoholic liver disease * Followed or seen at New York Presbyterian Hospital / Weill Cornell Medical Center * English speaking * Access to a smartphone

Exclusion criteria

* Unable to consent * Primary language other than English * No access to a smartphone

Design outcomes

Primary

Measure	Time frame	Description
Rates of recidivism	6 months	Rates of recidivism in this population using A-CHESS will be compared to historical control rates

Secondary

Measure	Time frame	Description
Use of A-CHESS	6 months	The association between the extent to which patients use the A-CHESS application and their recidivism; to compare use of the A-CHESS app among subjects who drink and remain abstinent.

Countries

United States

Contacts

Primary ContactNicole T Shen, MD

nts9004@nyp.org3146095911

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026